These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1637139

  • 21. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
    Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP.
    Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
    [Abstract] [Full Text] [Related]

  • 22. Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.
    Go KG, Kamman RL, Mooyaart EL, Heesters MA, Pruim J, Vaalburg W, Paans AM.
    Neuroradiology; 1995 Apr; 37(3):198-206. PubMed ID: 7603595
    [Abstract] [Full Text] [Related]

  • 23. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
    Shioya H, Mineura K, Sasajima T, Kowada M, Iida H, Ogawa T, Hatazawa J, Uemura K.
    No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
    [Abstract] [Full Text] [Related]

  • 24. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
    Barker FG, Chang SM, Valk PE, Pounds TR, Prados MD.
    Cancer; 1997 Jan 01; 79(1):115-26. PubMed ID: 8988735
    [Abstract] [Full Text] [Related]

  • 25. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
    Spence AM, Muzi M, Graham MM, O'Sullivan F, Krohn KA, Link JM, Lewellen TK, Lewellen B, Freeman SD, Berger MS, Ojemann GA.
    J Nucl Med; 1998 Mar 01; 39(3):440-8. PubMed ID: 9529289
    [Abstract] [Full Text] [Related]

  • 26. Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology.
    Anderson JH, Strandberg JD, Wong DF, Conti PS, Barker PB, Blackband SJ, Hilton J, Natarajan TK, Dannals RF, Samphilipo MA.
    Invest Radiol; 1994 Jun 01; 29(6):597-605. PubMed ID: 8088967
    [Abstract] [Full Text] [Related]

  • 27. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.
    Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, Hsu DW, Hochberg FH, Fischman AJ, Rosen BR.
    Clin Cancer Res; 2000 Jun 01; 6(6):2189-200. PubMed ID: 10873068
    [Abstract] [Full Text] [Related]

  • 28. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ, Hoffman JM, Coleman RE, Friedman AH, Hanson MW, Burger PC, Herndon JE, Meisler WJ, Schold SC.
    Ann Neurol; 1991 Apr 01; 29(4):347-55. PubMed ID: 1929205
    [Abstract] [Full Text] [Related]

  • 29. Combined hyperpolarized 13C-pyruvate MRS and 18F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients.
    Hansen AE, Gutte H, Holst P, Johannesen HH, Rahbek S, Clemmensen AE, Larsen MME, Schøier C, Ardenkjaer-Larsen J, Klausen TL, Kristensen AT, Kjaer A.
    Eur J Radiol; 2018 Jun 01; 103():6-12. PubMed ID: 29803387
    [Abstract] [Full Text] [Related]

  • 30. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
    De Witte O, Levivier M, Violon P, Salmon I, Damhaut P, Wikler D, Hildebrand J, Brotchi J, Goldman S.
    Neurosurgery; 1996 Sep 01; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
    [Abstract] [Full Text] [Related]

  • 31. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
    Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM.
    Radiology; 1995 Apr 01; 195(1):47-52. PubMed ID: 7892494
    [Abstract] [Full Text] [Related]

  • 32. Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy.
    Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Stanus E, Brotchi J, Hildebrand J.
    Cancer; 1996 Sep 01; 78(5):1098-106. PubMed ID: 8780549
    [Abstract] [Full Text] [Related]

  • 33. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
    Rozental JM, Levine RL, Nickles RJ.
    J Neurooncol; 1991 Feb 01; 10(1):75-83. PubMed ID: 2022974
    [Abstract] [Full Text] [Related]

  • 34. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.
    Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, Uemura K.
    Cancer; 1994 May 01; 73(9):2386-94. PubMed ID: 8168042
    [Abstract] [Full Text] [Related]

  • 35. Positron emission tomography in patients with glioma. A predictor of prognosis.
    Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M.
    Cancer; 1988 Sep 15; 62(6):1074-8. PubMed ID: 3261622
    [Abstract] [Full Text] [Related]

  • 36. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
    Tsuyuguchi N.
    Osaka City Med J; 1997 Dec 15; 43(2):209-23. PubMed ID: 9540343
    [Abstract] [Full Text] [Related]

  • 37. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.
    Fulham MJ, Bizzi A, Dietz MJ, Shih HH, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR, Di Chiro G.
    Radiology; 1992 Dec 15; 185(3):675-86. PubMed ID: 1438744
    [Abstract] [Full Text] [Related]

  • 38. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
    Shioya H, Mineura K, Kowada M, Iida H, Murakami M, Ogawa T, Hatazawa J, Uemura K.
    No Shinkei Geka; 1996 Mar 15; 24(3):211-9. PubMed ID: 8851949
    [Abstract] [Full Text] [Related]

  • 39. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET.
    Luyten PR, Marien AJ, Heindel W, van Gerwen PH, Herholz K, den Hollander JA, Friedmann G, Heiss WD.
    Radiology; 1990 Sep 15; 176(3):791-9. PubMed ID: 2389038
    [Abstract] [Full Text] [Related]

  • 40. Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy.
    Heesters MA, Kamman RL, Mooyaart EL, Go KG.
    J Neurooncol; 1993 Jul 15; 17(1):27-35. PubMed ID: 8120569
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.